Insider Trading activities of Oramed Pharmaceuticals Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oramed Pharmaceuticals Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oramed Pharmaceuticals Inc. since year 2005. Table 2 shows the detailed insider transactions of Oramed Pharmaceuticals Inc. since 2005. The reporting company's ticker symbol is ORMP. The reporting company's CIK number is 1176309.
The total value of stock buying since 2005 is $3,419,456.
The total value of stock sales since 2005 is $3,819,720.
The total value of stock option exercises since 2005 is $677,086.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Oramed Pharmaceuticals Inc. (ORMP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 0 $0 28,896 $135,639
2017-08 89,636 $761,906 89,636 $761,906 123,875 $491,672
2017-04 52,814 $334,312 52,814 $334,312 0 $0
2016-05 1,000 $6,978 0 $0 0 $0
2016-03 0 $0 8,500 $54,842 0 $0
2015-12 0 $0 52,000 $462,729 0 $0
2015-05 600 $3,966 0 $0 0 $0
2015-03 2,600 $10,121 0 $0 0 $0
2014-09 0 $0 40,000 $344,783 0 $0
2014-08 0 $0 0 $0 142,814 $1,713
2014-06 2,252 $9,998 0 $0 0 $0
2014-04 700 $10,087 137,300 $1,651,581 137,300 $1,647
2014-03 75,000 $796,835 9,434 $99,057 9,434 $46,415
2014-02 51,292 $800,761 0 $0 0 $0
2013-12 0 $0 834 $12,510 0 $0
2013-07 6,630 $49,035 0 $0 0 $0
2012-11 405,405 $0 0 $0 0 $0
2011-10 937,500 $300,000 0 $0 0 $0
2011-09 0 $0 350,000 $98,000 0 $0
2011-03 781,250 $250,000 0 $0 0 $0
2008-01 212,650 $62,277 0 $0 0 $0
2007-12 95,000 $23,180 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Oramed Pharmaceuticals Inc. insiders (ORMP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-31 Slager David Mark Option Ex 16,892 3.77 63,615
2017-10-23 Sank Leonard Option Ex 12,004 6.00 72,024
2017-08-17 Slager David Mark Option Ex 112,613 3.77 424,100
2017-08-15 Sank Leonard Option Ex 11,262 6.00 67,572
2017-08-02 Li Xiaopeng Buy 89,636 8.50 761,906
2017-08-02 Kidron Miriam (Chief Scientific Officer) Sale 89,636 8.50 761,906
2017-04-19 Li Xiaopeng Buy 52,814 6.33 334,312
2017-04-19 Kidron Miriam (Chief Scientific Officer) Sale 52,814 6.33 334,312
2016-05-12 Kidron Nadav (President and CEO) Buy 1,000 6.98 6,978
2016-03-10 Jacob Harold Sale 8,500 6.45 54,842
2015-12-30 Kidron Miriam (Chief Technology Officer) Sale 24,000 8.61 206,712
2015-12-29 Kidron Miriam (Chief Technology Officer) Sale 15,000 9.08 136,185
2015-12-28 Kidron Miriam (Chief Technology Officer) Sale 11,000 9.27 101,915
2015-12-09 Berelowitz Michael Sale 700 9.44 6,608
2015-12-08 Berelowitz Michael Sale 761 8.70 6,620
2015-12-07 Berelowitz Michael Sale 539 8.70 4,689
2015-05-12 Kidron Nadav (President and CEO) Buy 600 6.61 3,966
2015-03-19 Kidron Nadav (President and CEO) Buy 1,600 3.96 6,331
2015-03-18 Kidron Nadav (President and CEO) Buy 1,000 3.79 3,790
2014-09-11 Kidron Miriam (Chief Technology Officer) Sale 8,699 8.44 73,402
2014-09-10 Kidron Miriam (Chief Technology Officer) Sale 23,000 8.40 193,269
2014-09-04 Kidron Miriam (Chief Technology Officer) Sale 8,301 9.41 78,112
2014-08-01 Kidron Miriam (Chief Technology Officer) Option Ex 142,814 .01 1,713
2014-06-06 Slager David Mark Buy 2,252 4.44 9,998
2014-04-14 Jacob Harold Buy 700 14.41 10,087
2014-04-01 Kidron Miriam (Chief Technology Officer) Sale 137,300 12.03 1,651,581
2014-04-01 Kidron Miriam (Chief Technology Officer) Option Ex 137,300 .01 1,647
2014-03-31 Berelowitz Michael Sale 9,434 10.50 99,057
2014-03-31 Berelowitz Michael Option Ex 9,434 4.92 46,415
2014-03-25 Slager David Mark Buy 47,300 10.90 515,570
2014-03-24 Slager David Mark Buy 27,700 10.15 281,265
2014-02-06 Slager David Mark Buy 26,800 14.96 400,954
2014-02-05 Slager David Mark Buy 24,492 16.32 399,807
2013-12-30 Jacob Harold Sale 834 15.00 12,510
2013-07-10 Slager David Mark Buy 6,630 7.40 49,035
2012-11-02 Slager David Mark Buy 405,405 .00 0
2011-10-04 Sank Leonard Buy 937,500 .32 300,000
2011-09-27 Bronfeld Zeev Sale 350,000 .28 98,000
2011-03-31 Bronfeld Zeev (10% Owner) Buy 781,250 .32 250,000
2008-01-16 Sank Leonard (Director) Buy 5,000 .25 1,250
2008-01-15 Sank Leonard (Director) Buy 15,650 .25 3,912
2008-01-07 Sank Leonard (Director) Buy 22,840 .30 6,852
2008-01-03 Sank Leonard (Director) Buy 48,000 .30 14,400
2008-01-02 Sank Leonard (Director) Buy 121,160 .30 35,863
2007-12-31 Sank Leonard (Director) Buy 95,000 .24 23,180

Insider trading activities including stock purchases, stock sales, and option exercises of ORMP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oramed Pharmaceuticals Inc. (symbol ORMP, CIK number 1176309) see the Securities and Exchange Commission (SEC) website.